selenium has been researched along with Plasma Cell Tumor in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Behne, D; Bornkamm, GW; Dong, HF; Eckhaus, M; Felix, K; Gerstmeier, S; Howard, OM; Janz, S; Kyriakopoulos, A | 1 |
Johnson, RL; Strom, S; Uyeki, EM | 1 |
Baldew, GS; de Goeij, JJ; Los, G; McVie, JG; van der Valk, MA; Vermeulen, NP | 1 |
3 other study(ies) available for selenium and Plasma Cell Tumor
Article | Year |
---|---|
Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice.
Topics: Animals; Chemotaxis; Diet; Inflammation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Oxidation-Reduction; Peritoneal Neoplasms; Plasmacytoma; Selenium; Terpenes; Tissue Distribution | 2004 |
Mercury toxicity to hemopoietic and tumor colony-forming cells and its reversal by selenium in vitro.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Female; Hematopoietic Stem Cells; In Vitro Techniques; Mercury; Methylmercury Compounds; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Neoplasms, Experimental; Plasmacytoma; Selenium | 1979 |
Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Azoles; Cisplatin; Drug Administration Schedule; Drug Interactions; Female; Isoindoles; Kidney; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organoselenium Compounds; Plasmacytoma; Selenium; Time Factors | 1990 |